Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Kridin K, Ludwig RJ. The growing incidence of bullous pemphigoid: overview and potential explanations. Front Med (Lausanne). 2018;5:220.
2. Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022;36(10):1689–704.
3. Kridin K, Schwartz N, Cohen AD, et al. Mortality in bullous pemphigoid: a systematic review and meta-analysis of standardized mortality ratios. J Dermatol. 2018;45(9):1094–100.
4. Rosi-Schumacher M, Baker J, Waris J, et al. Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid. Front Immunol. 2023;14:1159351.
5. Sanchez-Garcia V, Perez-Alcaraz L, Belinchon-Romero I, et al. Comorbidities in patients with autoimmune bullous disorders: hospital-based registry study. Life (Basel). 2022;12(4):595.